Biodesix Inc
Diagnostics & Research
Healthcare
BDSX
146 M shares
NASDAQ US
traded
08 Jan 2025
listed
no
open
1.47
52 week high
2.12
high
1.48
52 week low
1.19
low
1.41
growth
-24.87 %
previous Close
1.49
P/E ratio
market cap
214 M
div yield
0
usd
Sep 2024
qoq
revenue
18.15 M
1.26 %
net incoming
-10.26 M
5.09 %
eps
0.00 %
12.50 %
eps surprise
0.00 %
net profit margin
-56.51 %
3.00 %
operating incoming
-8.59 M
-5.15 %
net change in cash
-10.83 M
-135.23 %
cash on hand
31.41 M
-25.79 %
cost of revenue
4.18 M
7.79 %
top top